scholarly journals A Modified Protocol to Maximize Differentiation of Human Preadipocytes and Improve Metabolic Phenotypes

Obesity ◽  
2012 ◽  
Vol 20 (12) ◽  
pp. 2334-2340 ◽  
Author(s):  
Mi-Jeong Lee ◽  
Yuanyuan Wu ◽  
Susan K. Fried
2016 ◽  
Vol 94 (suppl_5) ◽  
pp. 87-88
Author(s):  
M. A. Crookenden ◽  
C. G. Walker ◽  
A. Heiser ◽  
J. J. Loor ◽  
K. M. Moyes ◽  
...  

2018 ◽  
Author(s):  
Tim Hollstein ◽  
Takafumi Ando ◽  
Alessio Basolo ◽  
Jonathan Krakoff ◽  
Susanne Votruba ◽  
...  

2020 ◽  
Vol 21 (13) ◽  
pp. 1031-1039
Author(s):  
Suping Niu ◽  
Yan Li ◽  
Wenliang Dong ◽  
Lin Xia ◽  
Tiantian Shen ◽  
...  

Background: Desloratadine is a drug with a phenotypic polymorphism in metabolism and has been approved for use in many countries to treat allergic diseases. CYP2C8 and UGT2B10 are metabolic enzymes, which may be involved in the metabolism of desloratadine. Objective: This study aimed to demonstrate bioequivalence between the test product (desloratadine tablet) and the reference product AERIUS (5mg), both orally administered. And the role of UGT2B10 and CYP2C8 genotypes in healthy Chinese subjects with different Desloratadine metabolic phenotypes was examined. Methods: It was a randomized, open-label, and four-sequence, single-dose crossover study conducted on 56 healthy Chinese subjects. The pharmacokinetics (PK) and safety of the test and reference Desloratadine products were compared. UGT2B10 and CYP2C8 genotypes were determined by the TaqMan assay using genomic DNA. Multiple linear regression was applied to analyze the correlation between genotypes and the metabolic ratio. Results: The mean serum concentration-time curves of desloratadine and 3-OH-desloratadine were similar between the test product and the reference product. For the PK similarity comparison, the 90% CIs for the geometric mean ratios of Cmax, AUC0-t, and AUC0-∞ of desloratadine and 3-OH-desloratadine of test and reference product were completely within 80-125%. None of all 56 subjects had serious adverse events. Only 2 subjects were poor-metabolizers in 56 healthy subjects. There was no significant correlation between investigated genotypes of CYP2C8 and UGT2B10 and the metabolic ratio. Conclusion: The test desloratadine tablet was bioequivalent to the reference product. No direct relationship between CYP2C8 and UGT2B10 genotypes and desloratadine metabolic ratio was identified.


Diabetes ◽  
1998 ◽  
Vol 47 (8) ◽  
pp. 1365-1368 ◽  
Author(s):  
C. U. Niesler ◽  
K. Siddle ◽  
J. B. Prins

Diabetologia ◽  
2005 ◽  
Vol 48 (5) ◽  
pp. 886-891 ◽  
Author(s):  
A. Bennett ◽  
U. Sovio ◽  
A. Ruokonen ◽  
H. Martikainen ◽  
A. Pouta ◽  
...  

2001 ◽  
Vol 42 (5) ◽  
pp. 716-724
Author(s):  
Yan J. Jiang ◽  
Grant M. Hatch ◽  
David Mymin ◽  
Thomas Dembinski ◽  
Edwin A. Kroeger ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 1348
Author(s):  
Pratibha V. Nerurkar ◽  
Krupa Gandhi ◽  
John J. Chen

Metabolic syndrome (MetS) is prevalent not only among the overweight and obese but also normal weight individuals, and the phenotype is referred to as a metabolically unhealthy phenotype (MUHP). Besides normal weight individuals, overweight/obese individuals are also protected from MetS, and the phenotype is known as a metabolically healthy phenotype (MHP). Epidemiological studies indicate that coffee and micronutrients such as plasma folate or vitamin B12 (vit. B12) are inversely associated with MetS. However, correlations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 remain unknown. Our objective was to investigate the correlation between coffee consumption, metabolic phenotypes, plasma folate, and vit. B12 as well as to understand associations between plasma folate, vit. B12, and metabolic phenotypes. Associations among coffee consumption metabolic phenotypes, plasma folate, and vit. B12 were assessed in a cross-sectional study of 2201 participants, 18 years or older, from 2003–2004 and 2005–2006 National Health and Nutrition Examination Surveys (NHANES). MUHP was classified as having > three metabolic abnormalities. Coffee consumption was not associated with metabolic phenotypes, but negatively correlated with several metabolic variables, including BMI (p < 0.001). Plasma folate was positively associated with MUHP (p < 0.004), while vit. B12 was inversely associated with MUHP (p < 0.035). Our results suggest the potential protective impact of coffee on individual components of MetS and indicate a positive correlation between coffee consumption and MUHP among overweight individuals. Identifying possible dietary factors may provide practical and low-cost dietary intervention targets, specifically for early intervention. Larger and randomized intervention studies and prospective longitudinal studies are required to further evaluate these associations.


Sign in / Sign up

Export Citation Format

Share Document